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Sotos syndrome is an overgrowth syndrome characterized by pre- and postnatal overgrowth, macrocephaly, ad-
vanced bone age, variable degrees of mental retardation, and typical facial features. Defects of the NSD1 gene
account for 60% of cases of Sotos syndrome, whereas the disease-causing mechanism of other cases remains
unknown. Beckwith-Wiedemann syndrome (BWS) is a distinct overgrowth condition characterized by macroglossia,
abdominal-wall defects, visceromegaly, embryonic tumors, hemihyperplasia, ear anomalies, renal anomalies, and
neonatal hypoglycemia. Deregulation of imprinted growth-regulatory genes within the 11p15 region is the major
cause of BWS, whereas the molecular defect underlying a signiﬁcant proportion of sporadic BWS cases remains
unknown. Owing to clinical overlaps between the two syndromes, we investigated whether unexplained cases of
Sotos syndrome could be related to 11p15 anomalies and, conversely, whether unexplained BWS cases could be
related to NSD1 deletions or mutations. Two 11p15 anomalies were identiﬁed in a series of 20 patients with Sotos
syndrome, and two NSD1 mutations were identiﬁed in a series of 52 patients with BWS. These results suggest that
the two disorders may have more similarities than previously thought and that NSD1 could be involved in imprinting
of the chromosome 11p15 region.
Overgrowth syndromes are a heterogeneous group of
disorders resulting from the dysfunction of various pro-
cesses involving cell proliferation, cell growth, or apop-
tosis. Within this group, Sotos syndrome (MIM 117550)
is characterized by the combination of overgrowth, spe-
ciﬁc facial features (prominent forehead with receding
hairline, downslanting palpebral ﬁssures, and pointed
chin), large head circumference, and advanced bone age
(Sotos 1964; Cole and Hughes 1990, 1994). Variable
degrees of mental retardation are usually observed. Ad-
ditional features include neonatal hypotonia, seizures,
scoliosis, strabismus, congenital renal and heart defects,
and tumor predisposition. Deletions and point mutations
of the NSD1 gene (MIM 606681) account for 60% of
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cases of Sotos syndrome, but the disease-causing mech-
anism in other cases remains unknown (Kurotaki et al.
2002; Douglas et al. 2003; Rio et al. 2003).
On the other hand, Beckwith-Wiedemann syndrome
(BWS [MIM 130850]) is a distinct overgrowth condition
characterized by macroglossia, anterior abdominal wall
defects, visceromegaly, and tumor predisposition (Elliot
1994). Additional features include earlobe creases, pos-
terior helical ear pits, facial naevus ﬂammeus, neonatal
hypoglycemia, renal abnormalities, and hemihypertrophy.
A cluster of genes on chromosome 11p15 is involved in
the pathogenesis of BWS (Li et al. 1998; Maher and
Reik 2000; Reik and Murrell 2000). Although the ma-
jority of cases are sporadic, a small number of familial
forms are linked to chromosome 11p15. A minority of
cases result from 11p15 chromosome duplications and
translocations. Genetic causes (11p15 paternal unipar-
ental disomy or a mutation in CDKN1C) account for
30% of cases, and most patients exhibit epigenetic de-
fects, mostly demethylation of the KvDMR1 region of
the KCNQ1OT gene (MIM 604115) (60%) but also
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Table 1
Genotypes of Patient FD and His Parents at Polymorphic
Loci on Chromosome 11p15
LOCUSa
DISTANCE
FROM
TELOMEREb
(Mb)
GENOTYPE OF
Father Patient Mother
D11S4177 1.45 205 181/205 181/203
D11S4046 1.92 121/123 121 113/123
D11S1760 5.34 87/95 87 87
D11S1338 5.94 261/263 261 255/263
D11S1331 7.25 192/196 192 194/196
D11S909 8.81 116/118 118 114/118
D11S4188 9.12 108/116 108 112
D11S1346 11 268 268 268/280
D11S902 17.52 157 157 159/161
D11S904 26.71 194/200 194 186/188
D11S1751 33.79 204/214 204/212 212
NOTE.—Bold italic characters indicate genotypes that are
consistent with a maternal deletion or paternal isodisomy.
a Loci are listed according to their relative chromosomal lo-
cation from pter to centromere.
b Allele sizes are given in base pairs.
Figure 1 Methylation analysis of H19 and KCNQ1OT genes
in patients (RD and FD) and normal subjects (C). A, H19 methylation
was assessed by digestion with Pst1 and SmaI. The 1.8-kb Pst1 frag-
ment is cut with SmaI, resulting in a 1-kb fragment. The H19 methy-
lation index was determined by scanning autoradiographs and calcu-
lating the ratio (1.8-kb fragment)/(1.8-kb fragment  1-kb fragment)
# 100. B, KCNQ1OT methylation was assessed by digestion with
BamHI andNotI. The 6-kbBamHI fragment is cut withNotI, resulting
in a 4.2-kb fragment. The KCNQ1OT methylation index was deter-
mined by scanning autoradiographs and calculating the ratio (4.2-kb
fragment)/(4.2-kb fragment  6-kb fragment) # 100.
hypermethylation of the H19 gene (MIM 103280)
(10%). Altogether, these genetic and epigenetic abnor-
malities of the 11p15 region account for 80% of all
BWS cases (Li et al. 1998).
Although Sotos syndrome and BWS are believed to
be clinically distinct conditions, they share common
clinical features—namely, macrosomia, neonatal hypo-
glycemia, and cardiac anomalies. On the basis of this
phenotypic overlap, we hypothesized that some forms
of unexplained Sotos syndrome could be related to
11p15 anomalies, whereas unexplained BWS cases could
be related to NSD1 deletions or mutations.
We ﬁrst analyzed genomic DNA from 52 patients with
BWS for deletion of the NSD1 gene. Inclusion criteria
were the presence of at least two of the four major signs—
namely, (i) macrosomia, (ii) macroglossia, (iii) abdomi-
nal-wall defect, and (iv) organomegaly—and two minor
signs. In all cases, routine G-banding and R-banding
chromosome analyses showed a normal karyotype with
no evidence of deletions or duplications.Molecular analy-
ses of the 11p15 region ruled out chromosomal rear-
rangements as well as abnormal methylation patterns
and mutations in the CDKN1C gene. Patients were then
genotyped (according to the method of Rio et al. 2003)
using four polymorphic microsatellite markers (two in-
tragenic and two adjacent to the NSD1 gene) (UCSC).
In all cases, a microdeletion encompassing NSD1 was
excluded by the detection of two distinct alleles for at
least one of the intragenic markers. The 12/52 patients
with some degree of mental retardation were then se-
lected for NSD1 sequencing. It is interesting that two
patients with BWS were found to have NSD1 muta-
tions—namely, a 1-bp insertion in exon 14 (patient PB)
and a 4-bp deletion in exon 23 (patient BA). Both mu-
tations were found to have occurred de novo.
Conversely, 20 patients with Sotos syndrome were in-
vestigated for chromosomal and methylation anomalies
of the 11p15.5 region. They all presented with typical
facial gestalt, macrocephaly (head circumference 12
SD), overgrowth, and developmental delay. In all cases,
routine G-banding and R-banding chromosome analyses
showed a normal karyotype, and molecular analyses
ruled out fragile X syndrome and NSD1 deletion or
point mutation.
To screen for deletions or uniparental disomies of the
11p15.5 region, three polymorphic microsatellite mark-
ers (D11S4046, D11S1338, andD11S1346) (UCSC)were
tested. Analysis of one patient with Sotos syndrome (pa-
tient FD) revealed the unbalanced segregation of two
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Figure 2 Facial features of patients with BWS who have NSD1 mutations. A and B, Patient PB at age 1 year. Note that the craniostenosis
may hide the classic facial gestalt of Sotos syndrome. Frontal bossing and antimongoloid slant of the palpebral ﬁssure are not typical. C and
D, Patient BA at age 4 years. Note the absence of typical facial characteristics of Sotos syndrome: normo-versed nares and absence of prominent
forehead, dolichocephaly, and prominent chin.
microsatellite DNA markers, with no maternal contribu-
tion, at loci D11S4046 and D11S1338 (table 1). Geno-
typing eight additional polymorphic markers conﬁrmed
the lack of maternal contribution at loci D11S1331,
D11S4188, D11S902, and D11S904 and a balanced
contribution at loci D11S4177 and D11S1751. There-
fore, the disease region encompassed 25 Mb between
D11S4046 and D11S904. FISH analyses performed us-
ing YAC 896B12 and PAC RPCI-5 908H22, located on
distal chromosome 11p, detected two spots for each
probe, ruling out a maternal deletion and supporting
paternal isodisomy.
We subsequently investigated the methylation status
of the 11p15 region in our 20 patients with Sotos syn-
drome. That region contains two distinct domains that
are regulated by two independent imprinting centers sep-
arated by a nonimprinted region. The telomeric domain
1 contains the maternally expressed H19 gene and the
paternally expressed IGF2 gene. The centromeric do-
main 2 contains six known imprinted genes, including
the paternally expressed KCNQ1OT gene (LIT1) and
the maternally expressedCDKN1C gene (p57KIP2). The
methylation status of theKCNQ1OT andH19 genes was
assessed as described elsewhere (Brannan et al. 1990;Gas-
ton et al. 2001). As expected, patient FD, who had a
paternal isodisomy, exhibited a strong demethylation
pattern of the KCNQ1OT gene (methylation index [MI]
9.2%; normal ) (ﬁg. 1B).mean 1 SDp 51.6 2.5%
It is surprising, however, that we found an almost-nor-
mal methylation pattern of the H19 gene (MI 61%) (ﬁg.
Reports 719
Figure 3 Facial features in patients with Sotos who have 11p15 anomalies. A and B, Patient FD at age 11 years. Note the downslanting
palpebral ﬁssures and pointed chin. C and D, Patient RD at age 15 mo. Note the dolichocephaly, ocular hypertelorism, frontal bossing, sparseness
of hair in frontoparietal region, and antimongoloid slant of the palpebral ﬁssures.
1A). It is interesting that a second patient with Sotos
syndrome (patient RD) also displayed an abnormal
methylation status, as shown by the demethylation pat-
tern of the KCNQ1OT gene (MI 33.8%) (ﬁg. 1B). The
methylation status of the H19 gene was normal (MI
49.5%) (ﬁg. 1A). The other patients with Sotos syndrome
had a normal methylation pattern at the two loci.
Table 2 shows the clinical ﬁndings of the two patients
with BWS who had NSD1 mutations and the two chil-
dren with Sotos syndrome with anomalies of the 11p15
region. In all cases, careful analysis supported the initial
clinical diagnosis. Indeed, patient PB, who had a 1-bp
NSD1 deletion, ﬁrst received a diagnosis of BWS based
on pre- and postnatal overgrowth, umbilical hernia,
and hemihyperplasia. He also had mild developmental
delay, craniostenosis, andmultiple renal cysts.Moreover,
the patient did not have the typical facial gestalt ob-
served in patients with NSD1 anomalies (ﬁg. 2A and
2B). Similarly, patient BA, who had a 4-bp NSD1 de-
letion, ﬁrst received a diagnosis of BWS based on post-
natal overgrowth, hypoglycemia with hyperinsulinism, a
signiﬁcant umbilical hernia, and persistent vesicoureteral
reﬂux. This patient did not have the typical Sotos facies
either (ﬁg. 2C and 2D).
Conversely, patient RD was believed to have Sotos
syndrome on the basis of the association of postnatal
overgrowth, characteristic facial appearance, and de-
velopmental delay (ﬁg. 3A and 3B). The patient had a
partial isolated demethylation of KCNQ1OT, a feature
that is already reported in patients with BWS and is
probably due to mosaicism (Gaston et al. 2001). Simi-
larly, facial gestalt, advanced age bone, macrosomia and
720 Am. J. Hum. Genet. 74:715–720, 2004
overgrowth, ventriculomegaly, and ventricular septal de-
fect were consistent with the diagnosis of Sotos syn-
drome in patient FD (ﬁg. 3C and 3D). The patient had
a paternal isodisomy, including both KCNQ1OT and
H19 loci, and should therefore have an altered H19
methylation. His unusual methylation proﬁle may there-
fore be the cause of the atypical overgrowth phenotype
observed in him.
In conclusion, this study suggests that 11p15 anom-
alies could account for 10% of unexplained cases of
Sotos syndrome and, conversely, that NSD1 mutations
could account for5% of the unexplained cases of BWS.
These ﬁndings illustrate the difﬁculty in clinically rec-
ognizing the various overgrowth syndromes, owing to
their phenotypic overlap. These results suggest giving con-
sideration to testing the NSD1 gene and 11p15 region,
respectively, in individuals with atypical features of BWS
(i.e., unexplained developmental delay) and Sotos syn-
drome (i.e., hypoglycemia secondary to hyperinsulin-
ism). Finally, these results are also important for genetic
counseling and deﬁnition of recurrence risk in affected
families.
The mechanism by which mutations in theNSD1 gene
and deregulation of 11p15 genes result in similar phe-
notypes remains unknown.NSD1was isolated in a screen
to isolate C-regulators for retinoic acid receptors (Huang
et al. 1998). It encodes a nuclear protein containing an
SET (su(var)3-9, enhancer-of-zeste, trithorax)domainand
multiple PHD (plant homeodomain protein ﬁnger) do-
mains. Recent analyses of the mouse protein have shown
that the nsd1 SET domain has an intrinsic histonemethyl-
transferase with a unique substrate speciﬁcity for both
Lys36 of histone H3 and Lys20 of histone H4 (Rayasam
et al. 2003), suggesting an essential function in the tran-
scriptional gene silencing by histone methylation. On the
basis of these ﬁndings, it is tempting to speculate that
the NSD1 protein may also be involved in the estab-
lishment and/or maintenance of the imprinting of the
chromosome 11p15 region. We hope that further mo-
lecular and genetic studies will elucidate the exact link
between NSD1 and imprinting.
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